Search research articles
Contact Us
Filters
Showing results (221-230 of 451) with videos related to
Page
of 46
Sort By:
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
July 26, 2023
Prognostic Markers of DNA Methylation and Next-Generation Sequencing in Progressive Glioblastoma from the EORTC-26101 Trial
Tobias Kessler, Daniel Schrimpf, Laura Doerner, et al.
Proceedings of the National Academy of Sciences of the United States of America
|
August 21, 2013
Protein kinase Cβ as a therapeutic target stabilizing blood-brain barrier disruption in experimental autoimmune encephalomyelitis
Tobias V Lanz, Simon Becker, Matthias Osswald, et al.
Communications Medicine
|
December 19, 2023
Concurrent gliomas in patients with multiple sclerosis
Katharina Sahm, Tobias Kessler, Philipp Eisele, et al.
Cancer Medicine
|
September 29, 2020
Methylome analyses of three glioblastoma cohorts reveal chemotherapy sensitivity markers within DDR genes
Tobias Kessler, Anne Berberich, Ahmed Sadik, et al.
Nature Communications
|
August 5, 2017
Therapeutic radiation for childhood cancer drives structural aberrations of NF2 in meningiomas
Sameer Agnihotri, Suganth Suppiah, Peter D Tonge, et al.
Brain Pathology (Zurich, Switzerland)
|
October 8, 2015
Pediatric Targeted Therapy: Clinical Feasibility of Personalized Diagnostics in Children with Relapsed and Progressive Tumors
Florian Selt, Alica Deiß, Andrey Korshunov, et al.
Acta Neuropathologica
|
November 28, 2014
ATRX and IDH1-R132H immunohistochemistry with subsequent copy number analysis and IDH sequencing as a basis for an "integrated" diagnostic approach for adult astrocytoma, oligodendroglioma and glioblastoma
David E Reuss, Felix Sahm, Daniel Schrimpf, et al.
Neuro-Oncology
|
May 13, 2022
Diagnostic potential of extracellular vesicles in meningioma patients
Franz L Ricklefs, Cecile L Maire, Kathrin Wollmann, et al.
Journal of Neurochemistry
|
March 18, 2021
Diagnostic biomarkers from proteomic characterization of cerebrospinal fluid in patients with brain malignancies
Dominic Schmid, Uwe Warnken, Pauline Latzer, et al.
Neuro-Oncology
|
October 3, 2018
N2M2 (NOA-20) phase I/II trial of molecularly matched targeted therapies plus radiotherapy in patients with newly diagnosed non-MGMT hypermethylated glioblastoma
Wolfgang Wick, Susan Dettmer, Anne Berberich, et al.
Page
of 46
Search research articles
Search
Showing results (221-230 of 451) with videos related to
Sort By:
Page
of 46
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
July 26, 2023
Prognostic Markers of DNA Methylation and Next-Generation Sequencing in Progressive Glioblastoma from the EORTC-26101 Trial
Tobias Kessler, Daniel Schrimpf, Laura Doerner, et al.
Proceedings of the National Academy of Sciences of the United States of America
|
August 21, 2013
Protein kinase Cβ as a therapeutic target stabilizing blood-brain barrier disruption in experimental autoimmune encephalomyelitis
Tobias V Lanz, Simon Becker, Matthias Osswald, et al.
Communications Medicine
|
December 19, 2023
Concurrent gliomas in patients with multiple sclerosis
Katharina Sahm, Tobias Kessler, Philipp Eisele, et al.
Cancer Medicine
|
September 29, 2020
Methylome analyses of three glioblastoma cohorts reveal chemotherapy sensitivity markers within DDR genes
Tobias Kessler, Anne Berberich, Ahmed Sadik, et al.
Nature Communications
|
August 5, 2017
Therapeutic radiation for childhood cancer drives structural aberrations of NF2 in meningiomas
Sameer Agnihotri, Suganth Suppiah, Peter D Tonge, et al.
Brain Pathology (Zurich, Switzerland)
|
October 8, 2015
Pediatric Targeted Therapy: Clinical Feasibility of Personalized Diagnostics in Children with Relapsed and Progressive Tumors
Florian Selt, Alica Deiß, Andrey Korshunov, et al.
Acta Neuropathologica
|
November 28, 2014
ATRX and IDH1-R132H immunohistochemistry with subsequent copy number analysis and IDH sequencing as a basis for an "integrated" diagnostic approach for adult astrocytoma, oligodendroglioma and glioblastoma
David E Reuss, Felix Sahm, Daniel Schrimpf, et al.
Neuro-Oncology
|
May 13, 2022
Diagnostic potential of extracellular vesicles in meningioma patients
Franz L Ricklefs, Cecile L Maire, Kathrin Wollmann, et al.
Journal of Neurochemistry
|
March 18, 2021
Diagnostic biomarkers from proteomic characterization of cerebrospinal fluid in patients with brain malignancies
Dominic Schmid, Uwe Warnken, Pauline Latzer, et al.
Neuro-Oncology
|
October 3, 2018
N2M2 (NOA-20) phase I/II trial of molecularly matched targeted therapies plus radiotherapy in patients with newly diagnosed non-MGMT hypermethylated glioblastoma
Wolfgang Wick, Susan Dettmer, Anne Berberich, et al.
Page
of 46